THERAPEUTIC AGENT FOR GLAUCOMA CONTAINING ADENOSINE DERIVATIVE AS ACTIVE INGREDIENT
    1.
    发明申请
    THERAPEUTIC AGENT FOR GLAUCOMA CONTAINING ADENOSINE DERIVATIVE AS ACTIVE INGREDIENT 审中-公开
    含有腺苷衍生物的GLAUCOMA治疗药物作为主动成分

    公开(公告)号:US20100093770A1

    公开(公告)日:2010-04-15

    申请号:US12450832

    申请日:2008-04-14

    IPC分类号: A61K31/52 A61P27/06

    CPC分类号: A61K31/7076 C07H19/167

    摘要: A method for treating glaucoma or ocular hypertension comprising administering to a patient a pharmacologically effective amount of a compound represented by the following (1) or a salt thereof: wherein X represents CH or N; R1 represents a hydrogen atom, a hydroxy group, a halogen atom, an alkyl group, an alkoxy group, a cycloalkyl group, a cycloalkoxy group, a (cycloalkyl)methoxy group, or  R2 represents a hydrogen atom, an alkyl group, a cycloalkyl group, an alkylcarbonyl group or an alkyloxycarbonyl group; and Ra and Rb are the same or different and represent a hydrogen atom, a hydroxy group, a halogen atom, an alkyl group, an alkoxy group, a cycloalkyl group or a cycloalkoxy group.

    摘要翻译: 一种治疗青光眼或高眼压症的方法,其特征在于,向患者施用药理学有效量的下述(1)表示的化合物或其盐:其中,X表示CH或N; R1表示氢原子,羟基,卤素原子,烷基,烷氧基,环烷基,环烷氧基,(环烷基)甲氧基,或R2表示氢原子,烷基,环烷基 基团,烷基羰基或烷氧基羰基; R a和R b相同或不同,表示氢原子,羟基,卤素原子,烷基,烷氧基,环烷基或环烷氧基。